Suppr超能文献

了解特拉华州管制物质的处方开具与分发情况

Understanding Delaware Prescribing and Distribution of Controlled Substances

作者信息

Dydyk Alexander M., Sizemore Daniel C., Ravert Debra M., Porter Burdett R.

机构信息

Abrazo Central Campus

WVU Medicine

Abstract

Chronic pain and opioid use and abuse are significant problems in the United States. Over one-quarter of United States citizens suffer from chronic pain. It is among the most common complaints seen in an outpatient clinic and in the emergency department. Failure to manage chronic pain, as well as the possible complication of opioid dependence related to treatment, can result in significant morbidity and mortality. One in five patient complaints in an outpatient clinic is related to pain, with over half of all patients seeing their primary care provider for one pain complaint or another. It is paramount that providers have a firm grasp on the management of patients with chronic pain. As a country, the United States spends well over 100 billion dollars a year on healthcare costs related to pain management and opioid dependence. Pain-related expenses exceed those for the costs of cancer, diabetes, and heart disease combined. How a patient's chronic pain is managed can have profound and long-lasting effects on a patient's quality of life. The International Association for the Study of Pain defines chronic pain as any pain lasting longer than three months. There are multiple sources of chronic pain. Combination therapy for pain includes both pharmacological therapies and nonpharmacological treatment options. There is a more significant reduction in pain with combination therapy compared to a single treatment alone. Escalation of pharmacological therapy should be in a stepwise approach. Comorbid depression and anxiety are widespread in patients with chronic pain. Patients with chronic pain are also at increased risk for suicide. Chronic pain can impact every facet of a patient's life. Thus learning to diagnose and appropriately manage patients experiencing chronic pain is critical. Unfortunately, studies have revealed an inherent lack of education regarding pain management in most medical schools and training programs. The Association of American Medical Colleges recognized the problem and has encouraged schools to commit to opioid-related education and training by incorporating the Centers for Disease Control and Prevention guidelines for prescribing opioids for chronic pain into the medical school curriculum. Appropriate opioid prescribing includes prescribing sufficient opioid medication through regular assessment, treatment planning, and monitoring to provide effective pain control while avoiding addiction, abuse, overdose, diversion, and misuse. To be successful, clinicians must understand appropriate opioid prescribing, assessment, the potential for abuse and addiction, and potential psychological problems. Inappropriate opioid prescribing typically involves not prescribing, underprescribing, overprescribing, or continuing to prescribe opioids when they are no longer effective. The American Society of Addiction Medicine defines addiction as "a primary, chronic disease of brain reward, motivation, memory, and related circuitry."Individuals that become addicted to opioids or other medications often engage in behaviors that become compulsive and result in dangerous consequences. The American Society of Addiction Medicines notes that while the following should not be used as diagnostic criteria due to variability among addicted individuals, there are five characteristics of addiction: 1. Craving for drug or positive reward. 2. Dysfunctional emotional response. 3. Failure to recognize significant problems affecting behavior and relationships. 4. Inability to consistently abstain. 5. Impairment in control of behavior. Unfortunately, many health providers' understanding regarding addiction is confused, inaccurate, and inconsistent due to the broad range of perspectives of those dealing with patients suffering from addiction. While a knowledge gap is present among healthcare providers, it is equally prevalent in politicians writing laws and law enforcement attempting to enforce the laws they write. Payers are responsible for the expenses associated with the evaluation and treatment of addiction. Persistent lack of education and the use of obsolete terminology continue to contribute to a societal lack of understanding for how to effectively deal with the challenges of addiction. In the past, the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders defined "addiction," "substance abuse," and "substance dependence" separately. The result was provider confusion that contributed to the undertreatment of pain. Over time, the manual has eliminated these terms and now defines an inclusive "substance use disorder" ranging from mild to severe. Pain management presents numerous challenges, including avoidance of both under and overprescribing opioids. This is particularly relevant when treating patients with chronic pain. Many patients suffer from inadequately treated pain while at the same time there are issues of opioid abuse, addiction, diversion, and overdose. As a result of concerns related to overprescribing, providers often fail to deliver appropriate, effective, and safe opioids to patients with chronic pain. Providers have, in the past, been poorly trained and ill-informed in their opioid prescribing. Determining appropriate opioid therapy for chronic pain patients is even more difficult because these patients often develop opioid tolerance as well as significant psychological, behavioral, and emotional problems. These can include anxiety and depression related to under or overprescribing opioids.  Clinicians that prescribe opioids are at risk for allegations of medical negligence for failure to provide adequate pain control, while also risking loss of licensure or even criminal charges if they are perceived to be involved in drug diversion or misuse. All providers that prescribe opioids need education and training to provide the best patient outcomes and avoid the social and legal entanglements associated with under and overprescribing opioids. Opioid prescribing providers may have knowledge gaps in multiple areas, including current research, legislation, and appropriate prescribing practices. Specific opportunities for education include: Definition of addiction. Knowledge of at-risk populations. Distinction between prescription and non-prescription opioid addiction. Clarification of the difference between addiction and dependence. Dispelling the myth that opioid addiction is a psychologic problem rather than related to chronic, painful disease. The practice of opioid prescription has long been surrounded by misinformation, education deficits, and inconsistent laws, resulting in societal challenges that must be addressed with education and training.

摘要

慢性疼痛以及阿片类药物的使用和滥用是美国的重大问题。超过四分之一的美国公民患有慢性疼痛。这是门诊诊所和急诊科最常见的病症之一。未能有效管理慢性疼痛以及与治疗相关的阿片类药物依赖并发症,可能导致严重的发病率和死亡率。门诊诊所中五分之一的患者投诉与疼痛有关,超过一半的患者因各种疼痛问题就诊于初级保健医生。医疗服务提供者必须熟练掌握慢性疼痛患者的管理方法。作为一个国家,美国每年在与疼痛管理和阿片类药物依赖相关的医疗费用上支出超过1000亿美元。与疼痛相关的费用超过了癌症、糖尿病和心脏病的费用总和。患者慢性疼痛的管理方式会对其生活质量产生深远而持久的影响。国际疼痛研究协会将慢性疼痛定义为持续超过三个月的任何疼痛。慢性疼痛有多种来源。疼痛的联合治疗包括药物治疗和非药物治疗选择。与单一治疗相比,联合治疗能更显著地减轻疼痛。药物治疗的升级应采用逐步推进的方法。慢性疼痛患者中,共病的抑郁和焦虑很普遍。慢性疼痛患者的自杀风险也会增加。慢性疼痛会影响患者生活的方方面面。因此,学会诊断和妥善管理慢性疼痛患者至关重要。不幸的是,研究表明大多数医学院校和培训项目在疼痛管理方面存在教育缺失。美国医学院协会认识到了这个问题,并鼓励学校通过将疾病控制与预防中心关于慢性疼痛阿片类药物处方的指南纳入医学院课程,致力于与阿片类药物相关的教育和培训。合理的阿片类药物处方包括通过定期评估、治疗规划和监测来开具足够的阿片类药物,以有效控制疼痛,同时避免成瘾、滥用、过量、转移和误用。要取得成功,临床医生必须了解合理的阿片类药物处方、评估、滥用和成瘾的可能性以及潜在的心理问题。不合理的阿片类药物处方通常包括不开具、开具不足、开具过量或在药物不再有效时仍继续开具阿片类药物。美国成瘾医学协会将成瘾定义为“一种原发性慢性脑部奖赏、动机、记忆及相关神经回路疾病”。对阿片类药物或其他药物成瘾的个体通常会出现强迫行为,并导致危险后果。美国成瘾医学协会指出,虽然由于成瘾个体之间存在差异,以下内容不应作为诊断标准,但成瘾有五个特征:1. 渴望药物或积极奖赏。2. 功能失调的情绪反应。3. 未能认识到影响行为和人际关系的重大问题。4. 无法持续戒除。5. 行为控制受损。不幸的是,由于处理成瘾患者的人员观点广泛,许多医疗服务提供者对成瘾的理解混乱、不准确且不一致。虽然医疗服务提供者之间存在知识差距,但在制定法律的政治家和试图执行这些法律的执法人员中同样普遍存在。支付方负责与成瘾评估和治疗相关的费用。持续的教育缺失和过时术语的使用继续导致社会对如何有效应对成瘾挑战缺乏理解。过去,美国精神病学协会的《精神疾病诊断与统计手册》分别定义了“成瘾”“物质滥用”和“物质依赖”。结果导致医疗服务提供者的困惑,进而造成疼痛治疗不足。随着时间的推移,该手册已消除了这些术语,现在定义了一个从轻度到重度的包容性“物质使用障碍”。疼痛管理面临诸多挑战,包括避免阿片类药物开具不足和过量。这在治疗慢性疼痛患者时尤为重要。许多患者疼痛治疗不充分,同时存在阿片类药物滥用、成瘾、转移和过量问题。由于对开具过量的担忧,医疗服务提供者往往未能为慢性疼痛患者提供适当、有效和安全的阿片类药物。过去,医疗服务提供者在阿片类药物处方方面培训不足且信息匮乏。为慢性疼痛患者确定合适的阿片类药物治疗更加困难,因为这些患者通常会产生阿片类药物耐受性以及严重的心理、行为和情绪问题。这些问题可能包括与阿片类药物开具不足或过量相关的焦虑和抑郁。开具阿片类药物的临床医生可能因未能提供充分的疼痛控制而面临医疗过失指控,同时如果被认为参与药物转移或滥用,还可能面临执照吊销甚至刑事指控。所有开具阿片类药物的医疗服务提供者都需要教育和培训,以实现最佳的患者治疗效果,并避免与阿片类药物开具不足和过量相关的社会和法律纠纷。开具阿片类药物的医疗服务提供者可能在多个领域存在知识差距,包括当前研究、立法和合理的处方实践。具体的教育机会包括:成瘾的定义。对高危人群的了解。处方阿片类药物成瘾和非处方阿片类药物成瘾的区别。成瘾与依赖的区别。消除阿片类药物成瘾是心理问题而非与慢性疼痛疾病相关的误解。长期以来,阿片类药物处方实践一直被错误信息、教育不足和不一致的法律所包围,导致必须通过教育和培训来应对的社会挑战。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验